Key facts
- Outcomes4Me’s last known valuation is $92.0M (May 2025).
- It has raised $40.5M across 2 recorded rounds; the latest was Early Stage VC ($12.0M) in Apr 2021.
- Notable investors include Salica Investments, Sierra Ventures, Labcorp Venture Fund, Forecast Labs, Asset Management Ventures — 9 tracked in total.
- Outcomes4Me has filed 2 Form Ds with the SEC since 2020, most recently Apr 2021 ($12.0M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Outcomes4Me
Funding rounds
2 roundsAbout Outcomes4Me
Developer of a patient empowerment platform intended to offer a personalized, expert-validated evidence-based experience and disease-related information to patients. The company's platform offers clinical data to generate real-world evidence necessary to drive future clinical decisions and improve outcomes, enabling patients to facilitate informed decision-making and care management.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2017
- Employees
- 26
- Website
- outcomes4me.com/
- Ownership
- Privately Held (backing)
Outcomes4Me doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Outcomes4Me shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Outcomes4Me in its N-PORT filings yet. We sweep new filings monthly.